Imugene Limited (AU:IMU) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Imugene Limited announced that Jens Eckstein has ceased to be a director as of November 14, 2024, with significant holdings in stock options and ordinary shares. Eckstein was granted 2,000,000 restricted stock units under the company’s Employee Share Option Plan, approved by shareholders and set to vest over four years. This update might interest investors tracking leadership changes and insider holdings in the biotech sector.
For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.
